Project description
New workflows for personalised therapy in cancers
For clinical oncology providers, knowing the potential and the limitations of DNA sequencing can be critical for delivering genomic-supported care for patients. Thanks to technological advances a high-throughput of Next Generation Sequencing (NGS) can be applied in standard clinical practice. Amassed protocols for the analysis and interpretation of NGS data and knowledge bases, will allow clinicians to provide more targeted care for their patients. The EU funded Instand-NGS4P project will develop innovative NGS workflows from sample-pre-analytics focusing on conditions of patients for routine diagnostic of common-and-rare juvenile-and-adult cancers. A fully integrated and standardised NGS will be created with cooperation with leading medical centres with experience in NGS platforms in research, European patient advocacy groups and standardisation organisations.
Objective
Instand-NGS4P is a 65-month PCP project federating 7 leading medical centers (two are coordinating ERNs) as buyers’ group with major experience in using different NGS platforms in research and routine diagnostics. The consortium is further strengthened by European patient advocacy groups, a standardization organization and partners participating in the European infrastructures BBMRI-ERIC, ELIXIR as well as several NGS-related EU programs to cover all technical aspects and transversal needs & requirements. Driven by patient and clinical needs, innovative NGS workflows from sample-pre-analytics to medical decision making will be developed. The modular design of the workflow will particularly enable SEMs to contribute, and provides flexibility to adopt emerging user needs and technologies. Specifications will address regulatory requirements for IVDs and refer to international standards and requests development of reference materials and implementation of EQA schemes covering the whole workflow. R&D suppliers will be selected based on a public tender all along this PCP process in 3 phases according to the best-value for money solution. The 3 phases foresee the leverage of 4 technical modules (pre-analytics, sequencing, bioinformatics, e-reporting/e-medication) and their standardized interfaces – from design (Phase 1) to prototypes (Phase 2), and full integration in Phase 3. At the end, this PCP will provide 2 fully integrated, standardized NGS workflows for routine diagnostics of common and rare cancers from adults to children. In order to enable broad implementation in healthcare systems throughout Europe and beyond and to increase benefit to patients a series of support activities are planned including communication and dissemination activities targeting a broad stakeholder community, development of training and education material for healthcare professionals and patients, health economic assessment and engagement with healthcare payers and policy makers.
Fields of science
Keywords
Programme(s)
Topic(s)
Funding Scheme
PCP - Pre-Commercial ProcurementCoordinator
8010 Graz
Austria
See on map
Participants (23)
10787 Berlin
See on map
50121 Florence
See on map
3015 GD Rotterdam
See on map
Participation ended
1090 Wien
See on map
20126 Milano
See on map
L69 7ZX Liverpool
See on map
Participation ended
1210 Bruxelles / Brussel
See on map
8200 Aarhus
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
23562 Lübeck
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
24118 Kiel
See on map
00187 ROMA
See on map
1000 Bruxelles / Brussel
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
00029 Helsinki
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
Participation ended
400015 Cluj Napoca
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
4200-072 Porto
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
10060 Candiolo To
See on map
M13 9PL Manchester
See on map
Participation ended
69006 Lyon
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
1000 Ljubljana
See on map
80333 Muenchen
See on map
69373 Lyon
See on map
00014 Helsingin Yliopisto
See on map
1090 Wien
See on map